EPC:NYSEEdgewell Personal Care Company Analysis
Data as of 2026-07-05 - not real-time
$27.21
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Edgewell Personal Care (EPC) is trading at $27.21, just below its 52‑week high of $28.01 and the computed resistance level of $28.01. The stock sits above its 20‑day, 50‑day and 200‑day moving averages (23.81 > 21.36 > 20.06), and the MACD remains bullish, while a high RSI of 69.6 signals near‑term overbought pressure. Volume is increasing and beta is low at 0.35, suggesting limited market‑wide volatility, yet 30‑day price swings are elevated (~59 %).
Fundamentally, EPC posted modest revenue growth (0.6 %) and a healthy gross margin of 41 %, but profitability is still negative with a trailing EPS of –$0.23 and a profit margin of –3.5 %. Forward EPS is projected at $2.06, supporting a forward P/E of ~13, while the DCF fair value of $47.77 implies the current price is overvalued by roughly 10 %. The dividend yield of 2.21 % appears sustainable given a low payout ratio and positive free cash flow, though the company carries a high debt‑to‑equity ratio (~88 %) and a recent max drawdown of –41 %.
Fundamentally, EPC posted modest revenue growth (0.6 %) and a healthy gross margin of 41 %, but profitability is still negative with a trailing EPS of –$0.23 and a profit margin of –3.5 %. Forward EPS is projected at $2.06, supporting a forward P/E of ~13, while the DCF fair value of $47.77 implies the current price is overvalued by roughly 10 %. The dividend yield of 2.21 % appears sustainable given a low payout ratio and positive free cash flow, though the company carries a high debt‑to‑equity ratio (~88 %) and a recent max drawdown of –41 %.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish technical setup but RSI near overbought
- Price hugging resistance and above DCF fair value
- Recent market reaction to takeover rejection
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Forward earnings improvement and margin expansion
- Strategic exit from low‑margin feminine care segment
- Attractive dividend yield with low payout ratio
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Valuation gap versus DCF and analyst price targets
- High leverage and modest revenue growth
- Defensive consumer‑staples positioning with low beta
Key Metrics & Analysis
Financial Health
Revenue Growth0.60%
Profit Margin-3.48%
P/E Ratio13.2
ROE-0.71%
ROA3.20%
Debt/Equity88.36
P/B Ratio0.9
Op. Cash Flow$117.3M
Free Cash Flow$235.2M
Technical Analysis
TrendBullish
RSI69.6
Support$18.97
Resistance$28.01
MA 20$23.81
MA 50$21.36
MA 200$20.06
MACDBullish
VolumeIncreasing
Fear & Greed Index93.2
Valuation
Fair Value$47.77
Target Price$24.50
Upside/Downside-9.96%
GradeOvervalued
TypeBlend
Dividend Yield2.21%
Risk Assessment
Beta0.35
Volatility59.32%
Sector RiskLow
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.